Alopecia Market Top Scenario, SWOT Analysis, Business Overview & Forecast 2026

The global alopecia market size is anticipated to reach USD 4.8 billion by 2026, according to a report published by Radiant Insights, Inc., registering an 8.3% CAGR during the forecast period. The market is expected to be driven by increase in disease prevalence, technological advancements, and rise in per-capita healthcare expenditures across the globe.

The disease prevalence is increasing due to changing lifestyle patterns, such as increased consumption of alcohol and tobacco, changing food habits, high level of stress, and rising geriatric population. These factors are expected to boost the market over the forecast period. In addition, rising incidences of chronic diseases such as Polycystic Ovary Syndrome (PCOS), cancer, and rheumatoid arthritis are likely to fuel market growth.

Download Free Sample Report @ https://www.radiantinsights.com/research/alopecia-market/request-sample

Statistics presented by the National Alopecia Areata Foundation states that 147 million people worldwide, including 6.8 million people in U.S. alone, are affected by alopecia areata. Growing patient awareness about the disease and its treatment is anticipated to contribute to alopecia market growth. For instance, the Treatment Development Program (TDP) by National Alopecia Areata Foundation has resulted in an increase in research studies pertaining to this condition.

Currently, there are two FDA-approved therapeutics for the condition-Rogaine and Propecia. Generic penetration has significantly increased, following patent expirations of both drugs. However, impending launch of several promising pipeline candidates, such as Jakafi (ruxolitinib), Xeljanz (tofacitinib), Breezula (clascoterone), Lumigan (Bimatoprost), and SM04554 is expected to significantly drive the market in the near future.

Reimbursement coverage for treatment of this medical condition is one of the major challenges in this therapeutic landscape. Since most treatment modalities for this condition are considered cosmetic procedures and not medically essential, they are generally not covered under insurance. Out-of-pocket costs for this disease treatment usually include frequent doctor visits, prescription drug copays, and coinsurance for procedures.

Further key findings from the study suggest:

• High disease prevalence due to changing lifestyle patterns is the main factor driving the alopecia market

• Globally, lack of reimbursement policies will continue to restrain growth

• By disease type, alopecia areata accounted for more than 30.0% of the revenue in 2018

• Androgenetic alopecia, on the other hand, is expected to exhibit a CAGR of over 10.0% through 2026

• Homecare end-use settings are likely to be driven by increasing availability of OTC products and patient convenience

• Geographically, Asia Pacific is expected to demonstrate the fastest regional growth

Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/alopecia-market

Table of Contents

Chapter 1 Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. Radiant Insights internal database
1.3.3. Secondary sources & third party perspectives
1.3.4. Primary research
1.4. Information Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Data Visualization
1.6. Data Validation & Publishing

Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Alopecia Market Variables, Trends & Scope
3.1. Alopecia Market Lineage outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Regulatory Framework
3.4. Market Dynamics
3.4.1. Market driver analysis
3.4.1.1. Increasing global prevalence of alopecia
3.4.1.2. Rise in global healthcare expenditure
3.4.1.3. Growing incidence of chronic diseases
3.4.1.4. Technological advancements in alopecia treatment
3.4.2. Market restraint analysis
3.4.2.1. Lack of reimbursement policies
3.5. Alopecia Market Analysis Tools
3.5.1. Industry analysis - Porter’s
3.5.1.1. Supplier power: (Low due to large availability of products)
3.5.1.2. Buyer power: (High due to variety of options)
3.5.1.3. Substitution threat: (High due to replacements by transplantation)
3.5.1.4. Threat from new entrant: (High due to generic penetration)
3.5.1.5. Competitive rivalry: (High due to mergers & acquisitions by major players)
3.5.2. PESTEL analysis
3.5.2.1. Political landscape
3.5.2.2. Environmental landscape
3.5.2.3. Social landscape
3.5.2.4. Technology landscape
3.5.2.5. Legal landscape
3.5.3. Major deals & strategic alliances analysis
3.5.3.1. Joint ventures
3.5.3.2. Mergers & acquisitions
3.5.3.3. Licensing & partnership
3.5.3.4. Technology collaborations
3.5.3.5. Strategic divestments

Continued…

Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceutical

About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: sales@radiantinsights.com
Website: https://www.radiantinsights.com/